News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,781 Results
Type
Article (76482)
Company Profile (720)
Press Release (770552)
Multimedia
Podcasts (211)
Webinars (34)
Section
Business (228494)
Career Advice (3751)
Deals (39549)
Drug Delivery (165)
Drug Development (90029)
Employer Resources (206)
FDA (18253)
Job Trends (17270)
News (390146)
Policy (39104)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3033)
Academic (1)
Accelerated approval (46)
Adcomms (37)
Allergies (174)
Alliances (56208)
ALS (207)
Alzheimer's disease (1889)
Antibody-drug conjugate (ADC) (422)
Approvals (18489)
Artificial intelligence (699)
Autoimmune disease (251)
Automation (53)
Bankruptcy (405)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (222)
Biotechnology (443)
Bladder cancer (185)
Brain cancer (74)
Breast cancer (730)
Cancer (5682)
Cardiovascular disease (506)
Career advice (3222)
Career pathing (47)
CAR-T (331)
CDC (71)
Celiac Disease (2)
Cell therapy (898)
Cervical cancer (44)
Clinical research (76777)
Collaboration (2101)
Company closure (7)
Compensation (1330)
Complete response letters (92)
COVID-19 (3012)
CRISPR (111)
C-suite (1066)
Cystic fibrosis (161)
Data (7283)
Decentralized trials (3)
Denatured (78)
Depression (177)
Dermatology (63)
Diabetes (592)
Diagnostics (7407)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (340)
Drug pricing (238)
Drug shortages (38)
Duchenne muscular dystrophy (286)
Earnings (98644)
Editorial (71)
Employer branding (25)
Employer resources (174)
Events (135441)
Executive appointments (1116)
FDA (21844)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1740)
Gene editing (238)
Generative AI (70)
Gene therapy (746)
GLP-1 (1207)
Government (5464)
Grass and pollen (8)
Guidances (402)
Healthcare (20995)
HIV (80)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (329)
Immuno-oncology (92)
Indications (159)
Infectious disease (3360)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (282)
Interviews (731)
IPO (17906)
IRA (61)
Job creations (5019)
Job search strategy (2604)
JPM (73)
Kidney cancer (19)
Labor market (104)
Layoffs (665)
Leadership (46)
Legal (9982)
Liver cancer (106)
Longevity (29)
Lung cancer (762)
Lymphoma (417)
Machine learning (54)
Management (66)
Manufacturing (1016)
MASH (195)
Medical device (15128)
Medtech (15211)
Mergers & acquisitions (22822)
Metabolic disorders (1594)
mRNA (216)
Multiple sclerosis (183)
NASH (24)
Neurodegenerative disease (437)
Neuropsychiatric disorders (117)
Neuroscience (3422)
Neurotech (1)
NextGen: Class of 2026 (7665)
Non-profit (5129)
Now hiring (74)
Obesity (780)
Opinion (357)
Ovarian cancer (192)
Pain (249)
Pancreatic cancer (268)
Parkinson's disease (366)
Partnered (36)
Patents (583)
Patient recruitment (627)
Peanut (65)
People (66273)
Pharmaceutical (131)
Pharmacy benefit managers (36)
Phase 1 (23761)
Phase 2 (33477)
Phase 3 (25202)
Pipeline (7418)
Policy (370)
Postmarket research (3264)
Preclinical (10433)
Press Release (72)
Prostate cancer (292)
Psychedelics (61)
Radiopharmaceuticals (331)
Rare diseases (1124)
Real estate (7219)
Recruiting (81)
Regulatory (29025)
Reports (71)
Research institute (2748)
Resumes & cover letters (583)
Rett syndrome (34)
RNA editing (23)
RSV (96)
Schizophrenia (178)
Series A (293)
Series B (214)
Service/supplier (27)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4258)
State (2)
Stomach cancer (21)
Supply chain (132)
Tariffs (103)
The Weekly (130)
Vaccines (1231)
Venture capital (111)
Weight loss (531)
Women's health (117)
Worklife (23)
Date
Today (117)
Last 7 days (518)
Last 30 days (2784)
Last 365 days (32302)
2026 (8875)
2025 (32566)
2024 (37895)
2023 (42566)
2022 (53927)
2021 (58723)
2020 (57663)
2019 (51305)
2018 (39085)
2017 (36853)
2016 (37777)
2015 (43761)
2014 (38467)
2013 (34452)
2012 (36348)
2011 (36468)
2010 (35931)
Location
Africa (1216)
Alabama (100)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (50527)
Australia (8652)
California (12818)
Canada (3614)
China (1335)
Colorado (552)
Connecticut (557)
Delaware (387)
Europe (114544)
Florida (1919)
Georgia (421)
Hawaii (4)
Idaho (68)
Illinois (1065)
India (90)
Indiana (599)
Iowa (24)
Japan (509)
Kansas (137)
Kentucky (51)
Louisiana (44)
Maine (85)
Maryland (1583)
Massachusetts (9389)
Michigan (384)
Minnesota (727)
Mississippi (7)
Missouri (155)
Montana (37)
Nebraska (30)
Nevada (143)
New Hampshire (89)
New Jersey (3459)
New Mexico (33)
New York (3400)
North Carolina (1743)
North Dakota (10)
Northern California (6255)
Ohio (396)
Oklahoma (25)
Oregon (52)
Pennsylvania (2564)
Puerto Rico (28)
Rhode Island (53)
South America (1583)
South Carolina (79)
South Dakota (1)
Southern California (5005)
Tennessee (205)
Texas (2041)
United States (46078)
Utah (386)
Vermont (1)
Virginia (325)
Washington D.C. (88)
Washington State (1056)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
847,781 Results for "dainippon sumitomo pharma co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
April 1, 2026
·
10 min read
Press Releases
Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
December 9, 2025
·
14 min read
Press Releases
Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
November 3, 2025
·
9 min read
Press Releases
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
March 10, 2026
·
9 min read
Press Releases
Breckenridge Pharmaceutical enters strategic partnership with Maiva Pharma Pvt. Ltd.
March 11, 2026
·
2 min read
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
The approval of Eli Lilly’s oral obesity drug officially ignites an intense competition with Novo Nordisk’s oral Wegovy; Gilead Sciences and Neurocrine Biosciences keep the M&A train chugging; Trump hits pharma with his long promised tariffs, and the FDA proposes many changes with 2027 budget.
April 8, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Patents
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
February 18, 2026
·
4 min read
·
Shawna Williams
1 of 84,779
Next
